Hem › Kolorektal cancer › Connecticut › New Haven
Kliniska studier för Kolorektal cancer i New Haven, CT
20 studier för Kolorektal cancer söker deltagare vid platser i och runt New Haven (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
RekryterarFas 3
- Yale University School of Medicine /ID# 279373, New Haven
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekryterarFas 1/2
- Yale Cancer Center, New Haven
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekryterarFas 1
- Exelixis Clinical Site #62, New Haven
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
RekryterarFas 1/2
- Yale University School of Medicine, New Haven
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
RekryterarFas 1
- Yale Cancer Center, New Haven
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
RekryterarFas 2
- Yale New Haven Hospital /ID# 270565, New Haven
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
RekryterarFas 3
- Yale University School Of Medicine, New Haven
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekryterarFas 1/2
- Yale-New Haven Hospital-Yale Cancer Center, New Haven
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RekryterarFas 1
- Yale Cancer Center, New Haven
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RekryterarFas 1/2
- Yale University School of Medicine - Yale Cancer Center, New Haven
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
RekryterarFas 1
- Yale Cancer Center, New Haven
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RekryterarFas 3
- Clinical Study Site, New Haven
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
RekryterarFas 2
- Yale University, New Haven
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Yale University School of Medicine, New Haven
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
RekryterarFas 1/2
- Yale University, New Haven
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
RekryterarFas 1/2
- Yale Comprehensive Cancer Center, New Haven
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
RekryterarFas 1/2
- Yale University, New Haven
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekryterarFas 1
- Smilow Cancer Hospital (Yale University), New Haven
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
RekryterarFas 1
- Yale University, New Haven
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekryterarFas 1/2
- Yale University, Yale Cancer Center, New Haven
Kolorektal cancer-studier i andra städer
- Houston, TX102 studier
- New York City, NY78 studier
- Nashville, TN69 studier
- Boston, MA63 studier
- Los Angeles, CA59 studier
- Arlington, VA52 studier
- St. Louis, MO50 studier
- San Antonio, TX46 studier
- Philadelphia, PA44 studier
- Grand Rapids, MI40 studier
- Baldwin Park, CA37 studier
- Chicago, IL34 studier
Andra studier i New Haven
- Icke-småcellig lungcancer41 studier
- Bröstcancer38 studier
- Cancer (alla typer)33 studier
- Metastaserande cancer23 studier
- Lungcancer22 studier
- Plattenepitelcancer i huvud och hals22 studier
- Äggstockscancer21 studier
- Prostatacancer20 studier
- Akut myeloid leukemi17 studier
- Alkoholmissbruk (AUD)17 studier
- Opioidöverdos17 studier
- Bukspottkörtelcancer16 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.